CAXTON CORP 13D and 13G filings for Strongbridge Biopharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-05 12:50 pm Sale |
2021-10-05 | 13D | Strongbridge Biopharma plc SBBP |
CAXTON CORP | 0 0.000% |
-10,280,682 (Position Closed) |
Filing |
| 2020-09-23 10:37 am Purchase |
2020-09-17 | 13D | Strongbridge Biopharma plc SBBP |
CAXTON CORP | 10,280,682 15.200% |
1,765,853 (+20.74%) |
Filing |